The page cannot be displayed because you are using Internet Explorer version 8 or lower.

Please consider upgrading your browser here

We use cookies on this website. By using the website you accept our use of cookies. Accept

 
 
 
 

The Novozymes Prize

Emmanuelle Charpentier and Virginijus Siksnys received the 2017 Novozymes Prize. They received the Prize for their pioneering research activities, which have been key in developing the CRISPR-Cas9 genetic tool.

 

Focus on biotechnology

The Novozymes Prize aims to raise awareness of basic and applied biotechnology research.

The Prize is awarded to recognize outstanding research or technology contributions that benefit the development of biotechnological science for innovative solutions. It is awarded for a predominantly European contribution. Awardees must have a current position at a public or non-profit research institution in a European country. They can have any nationality.

The Novozymes Prize Committee awards the Prize based on the nominations received. Anyone can nominate a candidate for the Prize. 

The Prize is awarded annually and is of DKK 3 million. DKK 2.5 million is a funding amount for the awardee’s research, while DKK 0.5 million is a personal award. The Prize may not be awarded to members of the Board of the Novo Nordisk Foundation or members of committees or to members of boards, directors or employees of the Novo Group.

The Foundation’s collaborating partners and the winner’s guests attend the award ceremony in March, where the prize winner gives an introduction to his or her research. In addition, in celebration of the award, the recipient and the Foundation arrange an international symposium within the scientific field of the prize winner.

Watch videos with the two prize recipients here.

 

 

News room

Novozymes Prize won by researchers behind tools for editing the genes of organisms

Monday, 13 February 2017

The 2017 Novozymes Prize is being awarded to Emmanuelle Charpentier, Director and Scientific Member at the Max Planck Institute for Infection Biology in Berlin, Germany, and Virginijus Siksnys,...

Related Cases